The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration

被引:10
|
作者
Gillies, Mark C. [1 ]
Larsson, Jorgen [1 ]
机构
[1] Univ Sydney, Save Sight Inst, Dept Clin Ophthalmol, Sydney, NSW 2001, Australia
关键词
CLINICAL-TRIAL; ACETONIDE;
D O I
10.1016/j.ajo.2007.03.019
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To evaluate the effect of a single intravitreal injection of triamcinolone (IVTA) on central macular thickness and visual acuity in eyes with minimally classic exudative age-related macular degeneration (AMD). DESIGN- Retrospective, nonrandomized clinical interventional study. METHODS: Optical coherence tomography (OCT) and best,corrected logarithm of the minimum angle of resolution visual acuity were performed at baseline and one month after treatment. RESULTS: We identified I I eyes with foveal edema and minimally classic subfoveal neovascularization treated with an IVTA. Foveal edema decreased significantly from 401 98 mu m at baseline to 295 141 mu m (mean standard deviation; P = .004) at one month. There was, however, no significant change in visual acuity at one or three months after the intervention. CONCLUSIONS: This biological effect of IVTA does not support its clinical use, yet it does warrant further research to determine whether locally delivered cortico- steroids may be synergistic with other treatments. Reduction in foveal edema is not necessarily associated with improved visual function in exudative AMD.
引用
收藏
页码:134 / 136
页数:3
相关论文
共 50 条
  • [31] Intravitreal triamcinolone acetonide for diabetic macular edema
    Chieh, JJ
    Roth, DB
    Liu, M
    Belmont, J
    Nelson, M
    Regillo, C
    Martidis, A
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (07): : 828 - 834
  • [32] Intravitreal triamcinolone for macular edema in Lyme disease
    Michele Reibaldi
    Salvatore Faro
    Lorenzo Motta
    Antonio Longo
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246 : 457 - 458
  • [33] Intravitreal Triamcinolone for the Treatment of Diabetic Macular Edema
    Gomez-Ulla, Francisco
    Marticorena, Joaquin
    Alfaro, D. Virgil, III
    Fernandez, Maribel
    Mendez, Elizabeth Rodriguez
    Rothen, Michelle
    CURRENT DIABETES REVIEWS, 2006, 2 (01) : 99 - 112
  • [34] Foveal translocation for exudative age related macular degeneration
    McLeod, D
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (04) : 344 - 345
  • [35] Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone
    Larsson, J
    Zhu, MD
    Sutter, F
    Gillies, MC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (05) : 802 - 806
  • [36] The effect of intravitreal triamcinolone injection combined with vitrectomy for diabetic macular edema
    Fuseya, M
    Shinoda, H
    Shinoda, K
    Nagai, N
    Inoue, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U424 - U424
  • [37] Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration
    J B Jonas
    U H Spandau
    B A Kamppeter
    B Harder
    Eye, 2007, 21 : 387 - 394
  • [38] Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration
    Jost B. Jonas
    Ingrid Kreissig
    Robert Degenring
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2002, 240 : 872 - 873
  • [39] Prospective comparative study on intravitreal triamcinolone acetonide as treatment of exudative age-related macular degeneration
    Jonas, JB
    Kreissig, I
    Degenring, RF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U267 - U267
  • [40] Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration
    Jonas, J. B.
    Spandau, U. H.
    Kamppeter, B. A.
    Harder, B.
    EYE, 2007, 21 (03) : 387 - 394